Questcor Pharmaceuticals (NASDAQ:QCOR)
CAPS Rating:
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Inside ownership over 10%, no debt, ROE of 39, long term growth est 31%. Screen result.
I just ran the same screen now in April 2011 and QCOR is still there, while I am up with a CAP of 30 points on this one. I should leave it in the picked basket.